FDA Approved: REGADENOSON — Original Application (Apotex Corp.)

View source ↗

Summary

FDA approved Apotex Corp.'s generic Regadenoson for use as a pharmacologic stress agent in myocardial perfusion imaging to evaluate for coronary artery disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Regadenoson (Regadenoson)

Snippet

ORIG AP for REGADENOSON (REGADENOSON)